arrow
S

Samuel M. S. Cheng

university of washington seattle
H指数:27
被引数:4,337

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Strain-specific differences in the response to egg-derived versus recombinant protein influenza vaccines

对卵源蛋白与重组蛋白流感疫苗应答的菌株特异性差异

2026-05-011
OA
Antineuraminidase Antibody Responses in Older Adults After Consecutive Vaccinations With Enhanced Influenza Vaccines: A Randomized Controlled Trial

连续接种增强型流感疫苗后老年人抗神经氨酸酶抗体应答:一项随机对照试验

2025-12-080
OAAI
Humoral and cellular immunogenicity of a fourth dose BNT162b2 in children with chronic kidney diseases
2025-02-210
OAAI
Surveillance of coronaviruses in wild aquatic birds in Hong Kong: expanded genetic diversity and discovery of novel subgenus in the Deltacoronavirus

香港野生水禽中冠状病毒的监测:遗传多样性的扩展和新亚属在德尔塔冠状病毒中的发现

2025-01-010
OAAI
A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories

15个实验室SARS-CoV-2抗原性的全球协作比较

2024-12-180
OAAI
SARS- CoV-2-specific CD8+T cells from people with long COVID establish and maintain effector phenotype and key TCR signatures over 2 years

来自长COVID患者的传染性非典型肺炎CoV-2-specific CD8 T细胞建立并维持效应子表型和关键TCR特征超过2年

2024-09-160
OAAI
Antibody Fc receptor binding and T cell responses to homologous and heterologous immunization with inactivated or mRNA vaccines against SARS-CoV-2

用针对SARS-CoV-2的灭活或mRNA疫苗结合抗体Fc受体和T细胞对同源和异源预防接种的反应

2024-08-271
OAAI
A single-dose intranasal live-attenuated codon deoptimized vaccine provides broad protection against SARS-CoV-2 and its variants
2024-08-260
OAAI
Preliminary Findings From the Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE I) Study: A Randomized Controlled Trial
2024-07-231
OA